Vaxess timeline: The US biotech firm racing to bring its Covid-19 vaccine patch to clinical trials
Vaxess’ refrigeration-free, single-dose patch could offer significant benefits compared to traditional, injection-based vaccinations (Credit: Rido/Shutterstock)